CIK 0001175151 · Non-accelerated filer<br>Smaller reporting company
Cytosorbents Corp
Sign in to watch- Ticker
- CTSO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980373793
- Phone
- 973-329-8885
- Business address
- 305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- MedaSorb Technologies CORP, GILDER ENTERPRISES INC
- 10-K Report Annual Report
- 8-K Event Restatement
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Other acquisition Director acquired 10,000 shares (code O)
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Other acquisition President and COO acquired 12,000 shares (code O)
- 4 Other acquisition Chief Financial Officer acquired 32,625 shares (code O)
- 4 Other acquisition Chief Executive Officer acquired 34,168 shares (code O)
- 4 Other acquisition Director acquired 21,950 shares (code O)
- 8-K Event Regulation FD disclosure
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Option exercise Director acquired 15,879 shares (option exercise)
- 4 Option exercise President and COO acquired 31,760 shares (option exercise)
- 4 Option exercise Chief Medical Officer acquired 16,233 shares (option exercise)
- 4 Option exercise Director acquired 21,950 shares (option exercise)
- 4 Option exercise Chief Executive Officer acquired 90,832 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 32,625 shares (option exercise)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Results of operations · Regulation FD disclosure
Page 4 of 49 · 977 filings